The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Organizing pneumonia pattern (an area or areas of consolidation on imaging)
Publications
Faria IM, Zanetti G, Barreto MM, Rodrigues RS, Araujo-Neto CA, Silva JL, Escuissato DL, Souza AS Jr, Irion KL, Mançano AD, Nobre LF, Hochhegger B, Marchiori E
Organizing pneumonia: chest HRCT findings.
Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia. 2015;41(3):231-7
Organizing pneumonia: typical and atypical HRCT patterns.
La Radiologia medica. 2006;111(2):202-12
Drug-associated organizing pneumonia: high-resolution CT findings in 9 patients.
Journal of thoracic imaging. 2006;21(1):22-6
[Alveolar opacities and busulfan pneumonia].
Revue des maladies respiratoires. 1993;10(1):39-41
Busulphan lung.
Thorax. 1968;23(2):187-93
Busulfan lung. Report of two cases and review of the literature.
The American journal of roentgenology, radium therapy, and nuclear medicine. 1974;120(1):151-6
Diagnosis of busulfan lung by transcatheter biopsy.
Chest. 1973;64(6):771-3